bleximenib (JNJ-6617) - J&J
icovamenib (BMF-219) - Biomea Fusion
KO-2806 - Kura Oncology
ziftomenib (KO-539) - Kura Oncology, Kyowa Kirin
emilumenib succinate (DS-1594) - Daiichi Sankyo
Venclexta (venetoclax) - Roche, AbbVie
Revuforj (revumenib) - Syndax Pharma
enzomenib (DSP-5336) - Sumitomo Pharma, Kyoto University
https://clml-25-01.elsevierdigitaledition.com/
 
Sara Al Dali PharmaD 1; Abdulrahman F. Al-Mashdali MD 1; Anas Kalfah MD 1; Tareq Abuasab MD 2; Naval Daver MD 3; Shehab F. Mohamed MD 1
 
Aug 26, 2025
 
Next